Prime Minister Narendra Modi calls for collective effort to completely eliminate leprosy in India

2017-01-30 08:54:08

Prime Minister Narendra Modi has called for a collective effort to completely eliminate the ‘treatable disease’ of leprosy from India.By Team ABLEIn a message on the occasion of anti-leprosy day, the Prime Minister Narendra Modi said that we have to work together for socio-economic uplift of the cured persons and for their contribution in nation-building. He said we have to strive hard to ensu

Read more

Bengaluru gears up to host India Pharma 2017 & India Medical Device 2017 on February 11, 2017

2017-01-30 08:53:10

At the curtain raiser for the India Pharma & India Medical Device 2017, Union Minister for Chemicals & Fertilizers and Parliamentary Affairs, Ananth Kumar, informed that this international event will project India as an attractive investment destination.By Team ABLEThe Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Co

Read more

Hilleman Laboratories secures global patents for oral cholera vaccine

2017-01-30 08:51:57

The Oral Cholera Vaccine patents, assigned to Hilleman Laboratories, have been granted at various patent offices including USA, European Union, Australia, China, Canada and South Africa.By Team ABLEHilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, has announced that it has been awarded a set of global patents for its Oral Cholera Vaccine (OCV). The organization has

Read more

DBT, EMBO call for proposals through the Young Investigator Program

2017-01-30 08:50:46

The program identifies and supports some of the best young researchers in the life sciences. By Team ABLEThe Department of Biotechnology (DBT), an associate member of the European Molecular Biology Organization (EMBO), has called for proposals to the Young Investigator Program.The program identifies and supports some of the best young researchers in the life sciences. EMBO Young Investigators

Read more

Oxitec, GBIT launch Friendly Aedes mosquito 0utdoor caged trials in Dawalwadi

2017-01-27 10:46:19

Outdoor caged trials of Oxitec’s Friendly Aedes mosquito have been initiated to demonstrate the efficacy of the Friendly mosquitoes in suppressing the local Aedes aegypti population.By Team ABLEThe Gangabishan Bhikulal Investment and Trading Limited (GBIT) and Oxitec have co-launched the Friendly Aedes project in Dawalwadi, India. Outdoor caged trials of Oxitec’s Friendly Aedes mosquito have b

Read more

Globavir’s PanGlob Dengue rRT-PCR kit receives approval for sales and distribution in India

2017-01-27 10:42:48

Globavir Biosciences has received approval of its PanGlob Dengue rRT-PCR kit from the Ministry of Health & Family Welfare in India.By Team ABLEGlobavir Biosciences, a California-based biotechnology company developing dengue diagnostics and small molecule drugs to treat cancer and infectious diseases, has received approval of its PanGlob Dengue rRT-PCR kit from the Ministry of Health & Fami

Read more

GST on healthcare will make medicare unaffordable: ASSOCHAM-TechSci study

2017-01-27 10:40:48

The paper cautioned that if GST is levied on healthcare services and facilities, the much-avowed national goal to provide universal healthcare coverage would take a hit.By Team ABLE“The healthcare sector catering to the unmet health needs of the society should be kept out of the purview of the Goods and Services Tax (GST) or else medical care would become expensive and unaffordable for the commo

Read more

Ministry of Health, Malaysia awards Biocon three-year contract for supplying recombinant human insulin formulations

2017-01-25 16:00:32

Biocon will supply rh-insulin manufactured at its new facility in Malaysia to public sector hospitals and clinics through CCM Pharmaceuticals.By Team ABLEAsia\'s premier biopharmaceuticals company Biocon has announced that the Ministry of Health (MoH), Malaysia, has awarded a three-year contract, to its subsidiary, Biocon SDN BHD in Malaysia, for supplying recombinant human insulin (rh-insulin) fo

Read more

Biocon posts robust Q3 FY17 financial results; company’s net profit up 65% at Rs 171 crore

2017-01-25 15:56:12

Biocon has announced its consolidated financial results for the third quarter ended on December 31, 2016. By Team ABLEBiocon reported a revenue growth of 32 percent at Rs 1,092 crore in Q3 FY17, which was led by a robust growth of 61 percent in the biologics business, 24 percent growth recorded by small molecules, 18 percent by branded formulations and 17 percent growth by research services busine

Read more

MTal stresses on the need to incentivize investment for MedTech manufacturing to accelerate Make in India

2017-01-25 15:50:26

Pavan Choudary, Director General, Medical Technology Association of India (MTaI), urged for an urgent review of import duties on medical devices.By Team ABLEWith the Union Budget 2017 around the corner, the Medical Technology Association of India (MTaI) has stressed on certain expectations from on import duties. According to MTaI, the import duties on medical devices and equipments have already be

Read more